Company: ABBV
Filing Date: 2025-02-20
Form Type: 424B5
Source: 0001104659-25-015715
Chunk: 3

Company: AbbVie Inc.
Filing Date: 2025-02-20
Form: 424B5
Chunk 3
---
 (2035 Notes)           | ​ |

Co-Managers

| ​ | BNP PARIBAS                           
 (2030 Notes, 2035 Notes, 2055 Notes)​ | ​ | ​ | Citigroup                             
 (2028 Notes, 2030 Notes, 2035 Notes)​ | ​ | ​ | Deutsche Bank Securities              
 (2028 Notes, 2035 Notes, 2055 Notes)​ | ​ | ​ | Goldman Sachs & Co. LLC              
 (2028 Notes, 2030 Notes, 2035 Notes) | ​ |

| ​ | HSBC                                  
 (2028 Notes, 2035 Notes, 2055 Notes)​ | ​ | ​ | SOCIETE GENERALE                      
 (2028 Notes, 2030 Notes, 2055 Notes)​ | ​ | ​ | Wells Fargo Securities               
 (2028 Notes, 2030 Notes, 2055 Notes) | ​ |

| ​ | Lloyds Securities 
 (All Notes)​      | ​ | ​ | MUFG         
 (All Notes)​ | ​ | ​ | Santander    
 (All Notes)​ | ​ | ​ | TD Securities 
 (All Notes)   | ​ |

| ​ | US Bancorp   
 (All Notes)​ | ​ | ​ | Siebert Williams Shank 
 (All Notes)​           | ​ | ​ | Bancroft Capital 
 (All Notes)      | ​ |

| ​ | Cabrera Capital Markets LLC 
 (All Notes)​                | ​ | ​ | Independence Point Securities 
 (All Notes)​                  | ​ | ​ | R. Seelaus & Co., LLC 
 (All Notes)           | ​ |

The date of this prospectus supplement is February 18, 2025.

TABLE OF CONTENTS

TABLE OF CONTENTS

| ​                                               | ​ | ​ | Page |   |      |   | ​ |
| ABOUT THIS PROSPECTUS SUPPLEMENT                | ​ | ​ | ​    | ​ | S-1  | ​ | ​ |
| SUMMARY                                         | ​ | ​ | ​    | ​ | S-2  | ​ | ​ |
| RISK FACTORS                                    | ​ | ​ | ​    | ​ | S-5  | ​ | ​ |
| USE OF PROCEEDS                                 | ​ | ​ | ​    | ​ | S-9  | ​ | ​ |
| CAPITALIZATION                                  | ​ | ​ | ​    | ​ | S-